The Dark Story Behind Ozempic’s $500B Business Empire

Synopsis
Sam and Shaan trace the $500B Ozempic business back to processed food, the Flexner Report, doctors' lack of nutrition training, the cigarette industry's food play, American vs European candy, and a strong claim for psilocybin. Heavy pharma/health polemic.